POZ uses cookies to provide necessary website functionality, improve your experience, analyze our traffic and personalize ads. Our Privacy Policy
POZ uses cookies to provide necessary website functionality, improve your experience, analyze our traffic and personalize ads. By remaining on our website, you indicate your consent to our Privacy Policy and our Cookie Usage.
Emmanuel Garduque
There is a new drug named Sofosbuvir currently on the late stage of drug trial. According to what I have read, interferon is ousted from the combo drug therapy instead it will be only Sofosbuvir plus Ribavarin. This good news as Interferon has several unwanted side effects patients hate to experience. Nevertheless, prevention is better than cure
March 30, 2013